New HIV pill shows promise in early trial
Disease control
Completed
This study tested an experimental drug, STP0404, in 25 adults with HIV-1 who had never taken HIV medicines before. The goal was to see how well the drug lowers the amount of virus in the blood and if it is safe. Participants took the drug or a placebo for 10 days, and researchers…
Phase: PHASE2 • Sponsor: ST Pharm Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC